miércoles, 1 de marzo de 2017

Press Announcements > FDA approves Xermelo for carcinoid syndrome diarrhea

Press Announcements > FDA approves Xermelo for carcinoid syndrome diarrhea

u s food and drug administration



02/28/2017 04:30 PM EST


The U.S. Food and Drug Administration today approved Xermelo (telotristat ethyl) tablets in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid syndrome diarrhea that SSA therapy alone has inadequately controlled.

No hay comentarios:

Publicar un comentario en la entrada